{
    "2020-11-02": [
        [
            {
                "time": "",
                "original_text": "刘格菘第二！年内四只翻倍基金，他竟独占其三",
                "features": {
                    "keywords": [
                        "刘格菘",
                        "翻倍基金"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "盛视早参：调整有望结束 反弹或已开启",
                "features": {
                    "keywords": [
                        "调整",
                        "反弹"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞、恒瑞、泰格、石药、华兰生物……上市药企投资价值大PK，你最PICK谁？",
                "features": {
                    "keywords": [
                        "迈瑞",
                        "恒瑞",
                        "泰格",
                        "石药",
                        "华兰生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗(300760.SZ)三季度点评：业绩造好，市值新高，未来加速可期",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "业绩",
                        "市值"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "银河证券：10月金股组合跌1.15% 11月荐股名单出炉",
                "features": {
                    "keywords": [
                        "银河证券",
                        "金股组合",
                        "荐股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "社保基金最新持仓动向：狂买周期股，减持医药科技",
                "features": {
                    "keywords": [
                        "社保基金",
                        "周期股",
                        "医药科技"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "周期股",
                        "医药科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "【国元医药|点评】迈瑞医疗2020三季报点评：抗疫产品驱动业绩高增，品牌影响力显著提升",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "抗疫产品",
                        "业绩高增",
                        "品牌影响力"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迈瑞医疗(300760.SZ)三季度点评：业绩与估值共振，成长股前景可期",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "业绩",
                        "估值",
                        "成长股"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创业板企业三季度业绩同比增长30%",
                "features": {
                    "keywords": [
                        "创业板",
                        "业绩",
                        "增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "前三季度整体业绩亮眼，成创业板11周年‘生日礼’",
                "features": {
                    "keywords": [
                        "创业板",
                        "业绩",
                        "亮眼"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "创业板"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "疫情影响逐渐消退，关注高成长龙头+细分冠军 -- 医药生物上市公司2020年三季报小结",
                "features": {
                    "keywords": [
                        "疫情",
                        "高成长龙头",
                        "细分冠军",
                        "医药生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【浙商医药|三季报】医疗器械、服务：中国制造优势体现，推荐龙头",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "服务",
                        "中国制造",
                        "龙头"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}